Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INDIGO-FAPI: 68Ga-FAPI-46 PET for Earlier Pancreatic Cancer Diagnosis
NCT06659705Phase 2Recruiting
- Sponsor
- Institut Curie
- Start
- Dec 2025
- Primary completion
- Aug 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga FAPI-46 in pancreatic ductal adenocarcinoma (PDAC), sponsored by Institut Curie. Started Dec 2025; status: recruiting.
02
Drugs
68Ga FAPI-46
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT06659705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06659705.